Avalon GloboCare Files 8-K
Ticker: ALBT · Form: 8-K · Filed: Dec 1, 2025 · CIK: 1630212
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Avalon GloboCare filed a routine 8-K on 12/1/25. No major news.
AI Summary
Avalon GloboCare Corp. filed an 8-K on December 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this date.
Why It Matters
This 8-K filing indicates that Avalon GloboCare Corp. is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for reporting purposes and does not indicate any unusual or significant events.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- December 1, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-38728 (filing_id) — Commission File Number
- 47-1685128 (ein) — I.R.S. Employer Identification Number
- 4400 Route 9 South, Suite 3100, Freehold, NJ 07728 (address) — Principal executive offices
- 732-780-4400 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Avalon GloboCare Corp.?
The primary purpose of this 8-K filing is to serve as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically noting Regulation FD Disclosure and Financial Statements and Exhibits.
On what date was this 8-K report filed or effective?
The report was filed as of December 1, 2025, and the date of the earliest event reported is also December 1, 2025.
In which U.S. state is Avalon GloboCare Corp. incorporated?
Avalon GloboCare Corp. is incorporated in Delaware.
What is the principal executive office address for Avalon GloboCare Corp.?
The principal executive office address is 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
Does this filing indicate any specific material events or financial updates for Avalon GloboCare Corp. on December 1, 2025?
The filing indicates 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as items of disclosure, but does not detail specific material events or financial figures within the provided text.
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-12-01 09:29:01
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Capital M
Filing Documents
- ea0267822-8k_avalon.htm (8-K) — 27KB
- ea026782201ex99-1_avalon.htm (EX-99.1) — 19KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-25-116320.txt ( ) — 219KB
- albt-20251201.xsd (EX-101.SCH) — 3KB
- albt-20251201_lab.xml (EX-101.LAB) — 33KB
- albt-20251201_pre.xml (EX-101.PRE) — 22KB
- ea0267822-8k_avalon_htm.xml (XML) — 4KB
01. Financial Statement and Exhibits
Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of the Company dated December 1, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: December 1, 2025 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2